HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study.
about
Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women.Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions.Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistenceProspective study of human papillomavirus (HPV) types, HPV persistence, and risk of squamous cell carcinoma of the cervixSociodemographic and clinical factors of women with HPV and their association with HIVValidation of a low-cost human papillomavirus genotyping assay based on PGMY PCR and reverse blotting hybridization with reusable membranesComparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage studyHPV-based Tests for Cervical Cancer Screening and Management of Cervical Disease.Human papillomavirus 'reflex' testing as a screening method in cases of minor cytological abnormalities.The prevalence of human papillomavirus and its impact on cervical dysplasia in Northern CanadaGuidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention.A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study.Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions.Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland.Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women.Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping.Monitoring of human papillomavirus vaccination.Human papillomavirus testing and genotyping in cervical screening.Worldwide incidence of cervical lesions: a systematic review.Incidence of cervical intraepithelial neoplasia grade 2 or worse in colposcopy-negative/human papillomavirus-positive women with low-grade cytological abnormalities.Long-term risk of cervical intraepithelial neoplasia grade 3 or worse according to high-risk human papillomavirus genotype and semi-quantitative viral load among 33,288 women with normal cervical cytology.Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia.Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results.The HPV test has similar sensitivity but more overdiagnosis than the Pap test--a randomised health services study on cervical cancer screening in Finland.Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.HPV types in cervical cancer tissue in South Africa: A head-to-head comparison by mRNA and DNA tests.Sequencing analysis of HPV-other type on an HPV DNA chip.Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
P2860
Q30712681-60BF50E4-9161-46F1-A5A2-E5D873D51E80Q33574454-26B45BE6-274E-457F-8E72-65FD6ED88CBAQ34176414-E0D10B06-33A5-4F47-B570-1A8329294C9CQ34187128-9BEA62EB-1DCD-4A8F-9403-E741677ADEF0Q35222818-9400847C-9BA9-485F-BAD3-3621FD2738CFQ35273321-243D6D29-DE5D-46FD-A369-CBF0F16C6B92Q36423668-4D4779EA-706E-47D0-9D61-A6BA17E33481Q36856284-FF29048F-4DCB-40BC-A361-DCEFFE2B2CCBQ36858251-77540178-AD11-4A6E-AE25-2C20B239ACB7Q37056980-39882712-AC0C-4413-8006-2487CA839264Q37066141-DC1AE28A-C07D-49FE-AE43-338410ABCBF8Q37165122-206A3C14-89BE-47AA-8939-E55B2C56B419Q37287526-39853FF7-F665-4617-85D7-7CC3257B8963Q37352574-111528C6-78AE-47A0-92BB-6C6FD4A5A0E4Q37399223-49ECC2C1-0229-4BF6-9F6B-0D5A4A8A80CDQ37546224-A572A6B7-2E21-4F94-B946-98BF095D4558Q37808256-D992F8C0-B349-4430-A0D9-67DD4F59E034Q37909359-5EC874BD-37DB-480F-A632-066BD1102003Q38216073-96B88805-78AC-4E79-A42F-40AEA1D0B5E6Q39744848-76C1E201-9840-4238-8CB7-93CD2C8E1086Q41620477-DF75074B-18B3-43A9-83AF-1EDE85D8AA50Q42204957-BC786210-D336-4A10-B6EB-975524B49392Q42262648-EF41BCFF-AFC5-4F1A-B3C5-8F2C7EC62E8CQ43748680-F838E695-EDB5-477C-8868-B54E68AB7B15Q43780964-5ACDC647-5AA7-4D78-9EE2-0292423A96F4Q44876752-858E347A-C7D6-474E-A06A-7D455BB4C961Q47321818-FBD794F1-2AC2-40BD-9C9B-84EDFC383A5AQ51416546-4B349C19-A0A4-406E-9C52-24D971D4D0F5Q54983149-AE763FB2-2F63-4889-986C-7FA3E4F0C091
P2860
HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
HPV type-specific risks of hig ...... ation-based prospective study.
@ast
HPV type-specific risks of hig ...... ation-based prospective study.
@en
type
label
HPV type-specific risks of hig ...... ation-based prospective study.
@ast
HPV type-specific risks of hig ...... ation-based prospective study.
@en
prefLabel
HPV type-specific risks of hig ...... ation-based prospective study.
@ast
HPV type-specific risks of hig ...... ation-based prospective study.
@en
P2093
P2860
P356
P1476
HPV type-specific risks of hig ...... ation-based prospective study.
@en
P2093
Hansson BG
Rylander E
Törnberg S
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603843
P407
P577
2007-06-05T00:00:00Z
P5875
P6179
1039627720